Point72 Asset Management, L.P. 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:33 pm Sale | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | Point72 Asset Management, L.P. | 241,158 1.600% | -321,544 (-57.14%) | Filing |
| 2020-12-09 5:13 pm Purchase | 2020-12-04 | 13G | Regulus Therapeutics Inc. RGLS | Point72 Asset Management, L.P. | 562,701 8.500% | 562,701 (New Position) | Filing |